Gujarat Themis Biosyn Ltd announced the resignation of its CEO, Mr. Tapas Guha Thakurata, effective June 30, 2025, and the appointment of Dr. Sachin D. Patel as Managing Director for a five-year term starting July 1, 2025; the company also withdrew its merger plan with Themis Medicare Limited to focus on its core pharmaceutical business.